Skip to main content

Table 1 Baseline characteristics of the study population with a CVD event in the GBD subgroup

From: Gallbladder disease is associated with the risk of cardiovascular disease among Uyghurs in Xinjiang: a prospective cohort study

Variable

GBD

(χ2/Z)1

P 1

Non-GBD

(χ2/Z)2

P2

CVD

Non-CVD

CVD

Non-CVD

N (%)

401(34.04)

777(66.96)

  

799(7.78)

9467(92.22)

  

Age (years)

48.70 ± 13.78

41.49 ± 13.04

-8.49

 < 0.001

47.73 ± 13.79

34.70 ± 12.65

-24.76

 < 0.001

Male

131(32.67)

224(28.83)

1.85

0.174

364(45.56)

5154(54.44)

23.40

 < 0.001

Smoking (%)

44(10.97)

98(12.61)

0.67

0.413

96(12.02)

1774(18.74)

22.36

 < 0.001

Drinking (%)

12(3.99)

27(3.47)

0.19

0.661

28(3.50)

481(5.08)

3.89

0.049

Exercise (%)

58(14.46)

181(23.29)

12.75

 < 0.001

117(14.64)

1690(17.85)

5.23

0.022

ECG abnormality (%)

126(31.42)

286(36.81)

3.38

0.066

231(28.91)

2652(28.01)

0.29

0.588

Hypertension (%)

251(62.59)

226(29.09)

123.24

 < 0.001

385(48.19)

2431(25.68)

187.50

 < 0.001

T2DM (%)

64(15.96)

70(9.01)

12.68

 < 0.001

118(4.77)

420(4.44)

158.39

 < 0.001

Hyperbilirubinemia (%)

25(6.23)

65(8.37)

1.7

0.192

66(8.26)

808(8.53)

0.07

0.789

Dyslipidaemia (%)

17(4.24)

41(5.280)

0.61

0.436

89(11.14)

3273(34.57)

183.72

 < 0.001

Overweight (%)

324(80.80)

554(71.30)

12.57

 < 0.001

471(58.95)

5361(56.63)

111.79

 < 0.001

Abdominal obesity (%)

361(90.02)

638(82.11)

12.86

0.001

698(87.36)

6760(71.41)

94.37

 < 0.001

Family history of CVD (%)

78(19.45)

170(21.88)

0.94

0.333

118(14.77)

1403(14.92)

0.00

0.969

TG levels (mmol/L, %)

  

5.77

0.016

  

60.83

 < 0.001

 Low (< 1.70)

225(56.11)

492(63.32)

  

442(55.32)

6509(68.75)

  

 High (≥ 1.70)

176(43.89)

285(36.68)

  

357(44.68)

2958(31.25)

  

TC levels (mmol/L, %)

  

4.69

0.3

  

29.28

 < 0.001

 Low (< 5.20)

264(65.84)

559(71.94)

  

535(66.96)

7157(75.60)

  

 High (≥ 5.20)

137(34.16)

218(28.06)

  

264(33.04)

2310(24.40)

  

LDL levels (mmol/L, %)

 

0.05

0.826

  

10.35

0.001

 Low (< 3.40)

323(80.55)

630(81.08)

  

654(81.85)

8142(86.00)

  

 High (≥ 3.40)

78(19.45)

147(18.92)

  

145(18.15)

1325(14.00)

  

HDLlevels (mmol/L, %)

 

56.7

 < 0.001

  

1.72

0.190

 Low (≤ 1.00)

136(33.92)

116(14.93)

  

52(6.51)

738(7.80)

  

 High (> 1.00)

265(66.08)

661(85.07)

  

747(93.49)

8729(92.20)

  

UA levels (μmol/L, %)

  

2.87

0.9

  

0.00

0.968

 Low (< 404.60)

384(95.76)

758(97.55)

  

775(97.00)

9185(97.02)

  

 High (≥ 404.60)

17(4.24)

19(2.45)

  

24(3.00)

282(2.98)

  

WC (cm)

96.34 ± 12.33

93.10 ± 13.01

-4.47

 < 0.001

96.72 ± 14.00

89.60 ± 12.95

-14.23

 < 0.001

FBG (mmol/l)

5.40 ± 4.35

4.88 ± 1.76

-4.26

 < 0.001

5.30 ± 2.61

4.88 ± 1.52

-1.99

0.047

BMI (kg/m2)

27.83 ± 4.87

26.84 ± 4.77

-3.71

 < 0.001

27.46 ± 4.80

25.28 ± 4.47

-13.07

 < 0.001

TG (mmol/L)

1.98 ± 1.49

1.72 ± 1.26

-3.12

0.002

1.95 ± 1.46

1.63 ± 1.23

-7.96

 < 0.001

TC (mmol/L)

4.83 ± 1.06

4.65 ± 1.19

-3.09

0.002

4.79 ± 1.06

4.64 ± 2.00

-6.41

 < 0.001

UA (μmol/L)

262.30 ± 74.06

249.43 ± 72.90

-2.92

0.004

265.78 ± 70.24

256.06 ± 70.53

-3.74

0.004

SCr (μmol/L)

70.10 ± 15.61

67.69 ± 14.75

-2.19

0.029

70.93 ± 15.52

72.27 ± 14.34

-2.61

0.009

TBIL (μmol/L)

9.58 ± 5.02

10.80 ± 6.28

-4.11

 < 0.001

10.63 ± 6.34

10.58 ± 6.12

-0.09

0.930

IBIL (μmol/L)

6.41 ± 4.80

6.68 ± 6.19

-0.43

0.665

6.94 ± 6.27

6.23 ± 5.64

-3.04

0.002

DBIL (μmol/L)

4.39 ± 3.46

4.51 ± 2.08

-1.52

0.129

4.32 ± 2.07

4.57 ± 2.37

-3.13

0.002

LDL-c (mmol/L)

2.72 ± 0.74

2.68 ± 0.81

-0.6

0.547

4.32 ± 2.07

2.59 ± 0.74

-4.47

 < 0.001

HDL-c (mmol/L)

1.49 ± 0.53

1.47 ± 0.46

-0.51

0.612

1.44 ± 0.51

1.57 ± 0.55

-9.36

 < 0.001

SBP (mmHg)

139.77 ± 19.95

127.44 ± 17.07

-10.49

 < 0.001

138.53 ± 24.16

124.94 ± 17.00

-15.77

 < 0.001

DBP (mmHg)

79.52 ± 13.28

75.16 ± 11.54

-5.57

 < 0.001

79.45 ± 13.87

73.45 ± 11.72

-11.92

 < 0.001

eGFR (ml/min/1.73 m2)

95.60 ± 17.45

102.01 ± 17.84

-5.96

 < 0.001

97.56 ± 17.91

107.20 ± 17.83

-15.69

 < 0.001

  1. Values are presented as mean ± standard deviation or n (%). P1 = results of the chi-square or Mann–Whitney U-test for differences in baseline parameters of the participants with GBD between the CVD and non-CVD groups; P2 = results of the chi-square or Mann–Whitney U-test for differences in baseline parameters of the participants with non-GBD between the CVD and non-CVD groups
  2. (GBD gallbladder disease, ECG electrocardiography, T2DM type 2 diabetes mellitus, TG triglyceride, TC total cholesterol, LDL low-density lipoprotein cholesterol, HDL high-density lipoprotein cholesterol, UA uric acid, WC waist circumference, FBG fasting blood glucose, BMI body mass index, SCr serum creatinine, TBIL serum total bilirubin, IBIL indirect bilirubin, DBIL direct bilirubin, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, CVD cardiovascular disease)